Results 31 to 40 of about 28,671 (187)
Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus [PDF]
, 2014 In 2009, a novel lyssavirus (subsequently named Ikoma lyssavirus, IKOV) was detected in the brain of an African civet (Civettictis civetta) with clinical rabies in the Serengeti National Park of Tanzania.
Alejandro Nunez +21 more
core +2 more sources
Human Vaccines & Immunotherapeutics, 2017 This phase IV, single blind study assessed the immunogenicity and safety of India-manufactured purified chick embryo cell rabies vaccine (PCECV), compared with a German-manufactured batch obtained by the same production process.
Gadey Sampath +6 more
doaj +1 more source
Rabies elimination research: juxtaposing optimism, pragmatism and realism [PDF]
, 2017 More than 100 years of research has now been conducted into the prevention, control and elimination of rabies with safe and highly efficacious vaccines developed for use in human and animal populations. Domestic dogs are a major reservoir for rabies, and
Bögel K +13 more
core +1 more source
Ветеринария сегодня, 2020 Despite all the efforts made, the issue of rabies in the world does not lose its relevance. As an acute endemic infection, it poses a considerable danger to both animals and humans.
A. N. Balashov +5 more
doaj +1 more source
A thermostable messenger RNA based vaccine against rabies. [PDF]
PLoS Neglected Tropical Diseases, 2017 Although effective rabies virus vaccines have been existing for decades, each year, rabies virus infections still cause around 50.000 fatalities worldwide. Most of these cases occur in developing countries, where these vaccines are not available.
Lothar Stitz +8 more
doaj +1 more source
Anti-rabies vaccines applied in the Russian Federation and perspectives for their improvement
Вопросы вирусологии, 2022 Rabies is almost ubiquitous (except in certain areas) and poses a significant danger to both animals and humans. Every year around 55,000 people die from this disease worldwide.
A. L. Elakov
doaj +1 more source
The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees? [PDF]
, 2017 Could new oral vaccine technologies protect endangered wildlife against a rising tide of infectious disease? We used captive chimpanzees to test oral delivery of a rabies virus (RABV) vectored vaccine against Ebola virus (EBOV), a major threat to wild ...
Goetzmann, Jason E. +5 more
core +2 more sources
Journal of General Virology, 1983 Conclusions The secondary and tertiary structures of the rabies virus spike G protein are important for its ability to induce VN antibodies and confer immunity to the host. For a subunit peptide vaccine to be as effective as the native spike G protein, it would appear that the amino acid sequence comprising the antigenic determinant for VN antibody ...
W H, Wunner +3 more
openaire +2 more sources
Market mapping and landscape analysis of human rabies biologicals in India
Indian Journal of Public Health, 2019 Background: Rabies vaccines and immunoglobulins are lifesaving in humans following animal exposures. These biologicals should continuously be available throughout the year to prevent and eliminate human rabies by 2030. Objectives: The present study aimed
Mysore Kalappa Sudarshan +2 more
doaj +1 more source
Spatial expansions and travelling waves of rabies in vampire bats [PDF]
, 2016 A major obstacle to anticipating the cross-species transmission of zoonotic diseases and developing novel strategies for their control is the scarcity of data informing how these pathogens circulate within natural reservoir populations.
Benavides, Julio A. +2 more
core +1 more source